Discovering Trends in Chronic Fatigue Syndrome Patients' Clinical Study Experiences
Launched by POWER LIFE SCIENCES INC. · Jul 21, 2023
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding the experiences of patients with chronic fatigue syndrome who are participating in another study that tests a specific medical treatment. The researchers want to learn about how many patients complete the trial and how many choose to stop participating. By gathering this information, they hope to improve future clinical trials and outcomes for all patients with chronic fatigue syndrome, especially those from groups that are often overlooked.
To be eligible for this study, participants must be at least 18 years old, have not received any prior treatment for chronic fatigue syndrome, and be able to sign a consent form agreeing to take part. Individuals who are currently undergoing treatment in another study, cannot provide consent, or are women who could become pregnant without a negative pregnancy test are not eligible. If you decide to join, you can expect to share your experiences and contribute valuable information that could help others in the future. This study is currently not open for recruitment, but it aims to gather important insights once it begins.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Signed Written Informed Consent
- • Aged ≥ 18 years old
- • No prior treatment for chronic fatigue syndrome
- Exclusion Criteria:
- • Participant is actively receiving study therapy in another
- • Inability to provide written informed consent
- • Women of childbearing potential without a negative pregnancy test; or women who are lactating.
About Power Life Sciences Inc.
Power Life Sciences Inc. is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutic solutions across various medical disciplines. With a strong emphasis on scientific rigor and patient-centered approaches, the organization collaborates with leading researchers and healthcare professionals to design and execute clinical trials that prioritize safety, efficacy, and compliance. Power Life Sciences Inc. leverages cutting-edge technology and data analytics to streamline trial processes, enhance participant engagement, and accelerate the development of life-changing treatments, ultimately aiming to improve patient outcomes and contribute to the global healthcare landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Patients applied
Trial Officials
Michael B Gill
Study Director
Power Life Sciences Inc.
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported